UNASSIGNED: The change in @entity75 that develop after bilateral sagittal split osteotomy (BSSO) was explored, and the influence of the application of combination @entity856 ( @entity856 ), @entity13628 ( @entity13628 ), and @entity7613 ( @entity2186 ) on @entity1 outcomes was assessed. This was a randomized, controlled, double-blind trial. The study sample comprised 12 @entity1 , each evaluated on both sides (thus 24 sides). All @entity1 fulfilled defined selection criteria. Changes in the lesions were measured both subjectively and objectively. The sample was divided into two @entity1 groups: an experimental group receiving medication and a control group receiving placebo. The statistical analysis was performed using SPSS software. Lesions in both groups improved and no statistically significant difference between the groups was observed at any time. 'Severe' injuries in the experimental group were more likely to exhibit a significant improvement after 6 months. Based on the results of the present study, it is concluded that the combination @entity856 , @entity13628 , and @entity7613 did not influence recovery from @entity74 .

Effect of the use of combination XXXX , @entity13628 , and @entity7613 on the recovery of neurosensory disturbance after bilateral sagittal split osteotomy: a randomized, double-blind trial.

@entity1 :: ('9606', 'Species') :: ['patients', 'patient'] @entity75 :: ('MESH:D001927', 'Disease') :: ['neurosensory lesions'] @entity2186 :: ('MESH:D014805', 'Chemical') :: ['vitamin B12'] @entity13628 :: ('MESH:D003568', 'Chemical') :: ['CMP', 'cytidine monophosphate'] @entity856 :: ('MESH:D014544', 'Chemical') :: ['uridine triphosphate', 'UTP'] @entity74 :: ('MESH:D030342', 'Disease') :: ['neurosensory disorders'] @entity7613 :: ('MESH:D006879', 'Chemical') :: ['hydroxycobalamin']
@entity856 :: (MESH:D014544,Chemical) :: ['uridine triphosphate']
